Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
GENEREX BIOTECHNOLOGY CORP (GNBT)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Apr-30-21 | Jan-31-21 | Oct-31-20 | Jul-31-20 | Apr-30-20 | Jan-31-20 | Oct-31-19 | Jul-31-19 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | -32.5% | -19.9% | 2.2% | 21.8% | 59.6% | 56.2% | 68.2% | 72.2% |
| Gross profit | 132.5% | 119.9% | 97.8% | 78.2% | 40.4% | 43.8% | 31.8% | 27.8% |
| Selling, general and administrative | 1222.5% | 1133.7% | 1012.4% | 679.3% | 274.8% | 358.1% | 391.3% | 344.8% |
| Research and development | | | | 79.1% | | | | 28.2% |
| General and administrative | | | | 672.5% | | | | 344.8% |
| Depreciation | 37.8% | 35.6% | 33.5% | 31.2% | 7.8% | 7.3% | 9.7% | 6.9% |
| EBIT | -1198.7% | -1110.0% | -988.6% | -655.5% | -326.8% | -410.0% | -443.3% | -396.6% |
| Pre-tax income | -1286.8% | -1286.8% | -1286.5% | -1286.2% | -177.5% | -177.4% | -177.4% | -177.3% |
| Income taxes | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -1253.1% | -1253.1% | -1252.8% | -1252.5% | -150.6% | -150.6% | -150.6% | -150.4% |
|